Shire’s Dr Armin Reininger moves to Sobi

Stockholm-based Sobi has appointed Dr Armin Reininger as a senior vice president and head of global medical and scientific affairs.

Dr Reininger joins the rare diseases specialist from Shire, where he most recently served as head of medical affairs for haematology, EMEA at Baxalta, having first joined Baxter as head of global medical affairs for haemophilia.

Prior to this, Dr Reininger held several academic research and clinical positions at the Ludwig Maximillian University in Munich, Germany, The Scripps Research Institute, and Harvard Medical School.

Geoffrey McDonough, president and chief executive officer at Sobi, said: “We are truly delighted to welcome Armin to Sobi.

“Armin will apply his deep experience as an industry leader and academic in haemophilia to our team, as well as his global experience in medical scientific affairs to our stakeholders.”